Baker Brothers Advisors - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$2,208,000
-34.9%
955,690
+61.8%
0.01%
-42.9%
Q3 2020$3,391,000
+0.4%
590,761
+28.9%
0.01%
-6.7%
Q2 2020$3,377,000
+1531.4%
458,253
+559.6%
0.02%
+1400.0%
Q1 2020$207,000
-83.6%
69,471
-68.7%
0.00%
-87.5%
Q3 2018$1,260,000
-34.8%
222,139
-10.3%
0.01%
-46.7%
Q2 2018$1,932,000
+10.3%
247,7330.0%0.02%0.0%
Q1 2018$1,751,000
-46.8%
247,733
-25.7%
0.02%
-48.3%
Q4 2017$3,290,000
+15.2%
333,3330.0%0.03%
+26.1%
Q3 2017$2,857,000
-18.3%
333,3330.0%0.02%
-25.8%
Q2 2017$3,497,000333,3330.03%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,006,185$12,860,0005.90%
GLOBEFLEX CAPITAL L P 2,794,834$8,972,0000.92%
BVF INC/IL 6,631,051$21,286,0000.77%
EcoR1 Capital, LLC 6,082,200$19,524,0000.62%
CHI Advisors LLC 400,000$1,284,0000.43%
Ikarian Capital, LLC 705,082$2,264,0000.34%
Artal Group S.A. 2,500,000$8,025,0000.22%
DCF Advisers, LLC 141,701$455,0000.18%
PLATINUM INVESTMENT MANAGEMENT LTD 766,901$2,462,0000.07%
ACADIAN ASSET MANAGEMENT LLC 2,040,084$6,543,0000.02%
View complete list of OVID THERAPEUTICS INC shareholders